Developing a prototype HIV vaccine using nonhuman primates
Nonhuman primate studies for development of a prototype HIV vaccine that induces broadly neutralizing antibodies
This study is working on a new HIV vaccine by testing it in monkeys to see how well it can help their immune systems make powerful antibodies that fight the virus, which could lead to better vaccines for people in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11078953 on NIH RePORTER |
What this research studies
This research focuses on creating a prototype vaccine for HIV by studying nonhuman primates, specifically rhesus macaques. The team has made significant breakthroughs in understanding how to induce broadly neutralizing antibodies (bnAbs) that can effectively combat HIV. By immunizing these primates with specific antigens and observing their immune responses, researchers aim to identify the best methods for stimulating the production of these critical antibodies. The findings from these studies could provide valuable insights into vaccine development for humans.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would be individuals at high risk for HIV infection or those living with HIV who are seeking new treatment options.
Not a fit: Patients who are not at risk for HIV or those who have already developed advanced stages of HIV/AIDS may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to an effective HIV vaccine that provides long-lasting immunity against the virus.
How similar studies have performed: Other research has shown promise in similar approaches to vaccine development, particularly in the use of nonhuman primates to study immune responses.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Haynes, Barton F. — Duke University
- Study coordinator: Haynes, Barton F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.